Malignant neoplasm of lower-outer quadrant of right female breast. C50.511 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2019 edition of ICD-10-CM C50.511 became effective on October 1, 2018.
C50.511 is a valid billable ICD-10 diagnosis code for Malignant neoplasm of lower-outer quadrant of right female breast. It is found in the 2021 version of the ICD-10 Clinical Modification (CM) and can be used in all HIPAA-covered transactions from Oct 01, 2020 - Sep 30, 2021. ↓ See below for any exclusions, inclusions or special notations
Malignant neoplasm of lower-outer quadrant of right female breast. C50.511 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2020 edition of ICD-10-CM C50.511 became effective on October 1, 2019.
Codes C50 Malignant neoplasm of breast C50.0 Malignant neoplasm of nipple and areola C50.01 Malignant neoplasm of nipple and areola, female
Malignant neoplasm of breast ICD-10-CM C50. 419 is grouped within Diagnostic Related Group(s) (MS-DRG v39.0): 582 Mastectomy for malignancy with cc/mcc.
Malignant neoplasm of unspecified site of right female breast. C50. 911 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM C50.
C50. 911 Malignant neoplasm of unsp site of right female breast - ICD-10-CM Diagnosis Codes.
Z12. 31 Encntr screen mammogram for malignant neoplasm of breast - ICD-10-CM Diagnosis Codes.
Breast Cancer ICD-10 Code Reference SheetFEMALERightC50.811Malignant neoplasm of overlapping sites, right female breastC50.911Malignant neoplasm of unspecified site, right female breastD05.01Lobular carcinoma in situ, right breast9 more rows
- C50.919 (malignant neoplasm of. unspecified site of unspecified female. breast)
ICD-10 code N63. 1 for Unspecified lump in the right breast is a medical classification as listed by WHO under the range - Diseases of the genitourinary system .
A malignant tumor at the original site of growth. [ from NCI]
A malignant neoplasm (NEE-oh-plaz-um) is another term for a cancerous tumor. The term “neoplasm” refers to an abnormal growth of tissue. The term “malignant” means the tumor is cancerous and is likely to spread (metastasize) beyond its point of origin.
Z12. 31 (Encounter for screening mammogram for malignant neoplasm of breast) is reported for screening mammograms while Z12. 39 (Encounter for other screening for malignant neoplasm of breast) has been established for reporting screening studies for breast cancer outside the scope of mammograms.
39 (Encounter for other screening for malignant neoplasm of breast). Z12. 39 is the correct code to use when employing any other breast cancer screening technique (besides mammogram) and is generally used with breast MRIs.
ICD-10 code R92. 8 for Other abnormal and inconclusive findings on diagnostic imaging of breast is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .
Malignant neoplasm of lower-outer quadrant of breast 1 C50.5 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail. 2 The 2021 edition of ICD-10-CM C50.5 became effective on October 1, 2020. 3 This is the American ICD-10-CM version of C50.5 - other international versions of ICD-10 C50.5 may differ.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Primary malignant neoplasms overlapping site boundaries.
A malignant neoplasm in which there is infiltration of the skin overlying the breast by neoplastic large cells with abundant pale cytoplasm and large nuclei with prominent nucleoli (paget cells). It is almost always associated with an intraductal or invasive ductal carcinoma of the breast.
genes - there are two genes, brca1 and brca2, that greatly increase the risk. Women who have family members with breast or ovarian cancer may wish to be tested.
An intraductal carcinoma of the breast extending to involve the nipple and areola, characterized clinically by eczema-like inflammatory skin changes and histologically by infiltration of the dermis by malignant cells (paget's cells). (Dorland, 27th ed) Breast cancer affects one in eight women during their lives.
Breast self-exam and mammography can help find breast cancer early when it is most treatable. Treatment may consist of radiation, lumpectomy, mastectomy, chemotherapy and hormone therapy.men can have breast cancer, too, but the number of cases is small. nih: national cancer institute.
C50.511 is a valid billable ICD-10 diagnosis code for Malignant neoplasm of lower-outer quadrant of right female breast . It is found in the 2021 version of the ICD-10 Clinical Modification (CM) and can be used in all HIPAA-covered transactions from Oct 01, 2020 - Sep 30, 2021 .
Diagnosis for females only - The diagnosis code can only apply to a female patient.